Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Back to BASICS: Boric Acid vs Metronidazole for Bacterial Vaginosis
NCT00799214Phase 3Completed
- Sponsor
- University of British Columbia
- Start
- Apr 2014
- Primary completion
- Nov 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of boric acid in bacterial vaginosis (BV) (3 arms), sponsored by University of British Columbia. Primary endpoint: Proportion of women with Nugent score < 7 at Day 17. Started Apr 2014; status: completed.
02
Drugs
boric acid
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT00799214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00799214.